EVMN

EVOMMUNE INC

Data as of 2026 Q2 (06-30) · 13F snapshot

Summary

EVOMMUNE INC (EVMN) is held as common stock by 3 tracked hedge-fund managers, with a combined reported value of ~$30.48M; the largest are Steven Cohen, Baker Bros. Advisors, Ken Griffin. 1 tracked manager also disclosed PUT or CALL positions, reported separately below. This quarter: 1 new, 1 added. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.

Attention · LowThis quarter · Heating up

Common-stock holders31 also report options

Congress trades0

Price$8.35vs quarter-end-37.17%

Sectors0

This quarter's moves

New1

Added1

Trimmed / sold0

Top holder

Steven Cohen

Common-stock positions

PUT and CALL disclosures are excluded from these holder counts and values.

Baker Bros. AdvisorsHold

Value $11.26M0.1% of portfolio847,3902026 Q2

Investor	Period	Value	Shares	% of portfolio	Action
Baker Bros. Advisors	2026 Q2	$11.26M	847,390	0.1%	Hold

PUT / CALL disclosures

Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.

Ken GriffinPUT—

Value $494.4K— of portfolio37,2002026 Q2

Investor	Period	Value	Shares	% of portfolio	Action
Ken GriffinPUT	2026 Q2	$494.4K	37,200	—	—

Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.